TY  - GEN
AU  - Bellone,Stefania
AU  - Buza,Natalia
AU  - Choi,Jungmin
AU  - Zammataro,Luca
AU  - Gay,Laurie
AU  - Elvin,Julia
AU  - Rimm,David L
AU  - Liu,Yuting
AU  - Ratner,Elena S
AU  - Schwartz,Peter E
AU  - Santin,Alessandro D
TI  - Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement
SN  - 1557-3265
PY  - 2019///1220
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Agents, Immunological
KW  - B7-H1 Antigen
KW  - genetics
KW  - Biomarkers, Tumor
KW  - Biopsy
KW  - Computational Biology
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gene Rearrangement
KW  - HLA Antigens
KW  - immunology
KW  - Humans
KW  - Molecular Targeted Therapy
KW  - Mutation
KW  - Ovarian Neoplasms
KW  - diagnosis
KW  - Positron Emission Tomography Computed Tomography
KW  - Programmed Cell Death 1 Receptor
KW  - antagonists & inhibitors
KW  - Receptors, Cell Surface
KW  - Retreatment
KW  - T-Lymphocytes
KW  - drug effects
KW  - Treatment Outcome
KW  - Exome Sequencing
N1  - Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-17-1805
ER  -